segunda-feira, 16 de novembro de 2026
PesquisarExplore
Inteligência rastreável à fonte

Notícias em que pode confiar

Cada facto rastreado até à sua fonte, e verificado. Explore as empresas, os factos e as conclusões por trás das notícias.

O que estamos a observar

Conclusões que a nossa IA está a tirar dos factos rastreados: leia-as como interpretação, cada uma sustentada nos dados e nas entidades que menciona.

cycle· bullish

Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge

Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.

ECLIPSE 1ECLIPSE 2ECLIPSE 3Phase 2 SOLSTICE trial
transformation· mixed

Q4 2026 Boardroom Reckoning: Activism, Unsolicited Bids and Leadership Succession

Boards are working through a dense stretch of governance events: Helen of Troy rejecting Empower Brands' $37 cash proposal, Oasis's nominee standing at Vail Resorts' Dec 14 meeting, and a BAM take-private proposal for BEEP under special committee review. Planned CEO successions (Davis succeeding Hogan at Align), board refreshes (Mineralys, Fractyl, Bausch + Lomb), SPAC extensions (Globa Terra) and wind-downs (Elme Communities) add to the picture. Universal proxy card rules have pushed activist campaigns toward negotiated settlements. AI is a smaller thread: employers are warned that staff running confidential data through consumer AI tools may breach trade-secret agreements, which is prompting rewrites of confidentiality and invention-assignment contracts.

Helen of Troy Board of DirectorsVail Resorts 2026 Annual Meeting of StockholdersM. Ashton HudsonUniversal proxy card rules
transformation· mixed

Q3 2026 CFO Playbook: Cost Discipline, Liquidity Preservation and Portfolio Reshaping Ahead of 2027

CFOs across biotech, medtech, energy, mining, semiconductors and fintech/adtech are using Q3 2026 earnings to stress cash preservation, cost cuts and integration wrap-up. Examples include Fractyl's ~50% cut in cash burn, TriSalus's lower-burn growth plan, Infineon's falling idle costs, and NGS's final integration quarter. Capital moves are also under way: Atrium's $50M placement, a credit-facility redraw to repay convertibles, Eagle Ford and Lubes divestitures/spinoffs, and System1's planned NYSE delisting. Regulatory events (Durbin Amendment impact on Origin Bancorp, the FDA PDUFA date for ivonescimab, the Florida City Gas rate case, Alberta auto reform) set the 2027 backdrop. Little of this material concerns AI or fintech directly; the link is the Startpage monetization pressure at System1 and the Durbin effect on bank interchange.

Lara WeberTridivesh KidambiBrendan WinslowIan Eckert
transformation· mixed

Biotech Clinical Progress Meets AI-Driven Discovery Amid a Risk-Off Tech and Funding Shock

Biotech fundamentals are advancing on several fronts: Vor Biopharma's TELIGAN Phase 3 win, Incyte's PDAC data, Scribe's in vivo CRISPR program with $174.2M cash, and AI-designed viruses treating a first patient at Radical Numerics. Meanwhile, a $1 trillion tech selloff, OpenAI cutting its funding target and $3.6B in Binance withdrawals show a risk-off turn in AI and crypto capital markets. Biotech is therefore pairing real clinical and AI-enabled progress with a tighter funding backdrop, so the winners are likely to be companies with cash runways and late-stage data. Eli Lilly's strong demand and BioArctic's royalty growth show where revenue is already flowing.

Scribe Therapeutics Inc.Vor Biopharma Inc.Incyte CorporationRadical Numerics
cycle· mixed

Big Tech Selloff and Hot Inflation Meet Resilient Financial-Sector Q3 Earnings

In early November 2026 the Nasdaq had its worst day since April 2025 and the Magnificent Seven lost over $1 trillion. Pressure came from a hotter-than-expected October CPI and Democratic plans to rein in Big Tech. Meanwhile, financial services firms (East West, FNF, Aventus, LY Corp, Canara HSBC Life) reported solid Q3 results with raised guidance, fee growth and deal activity, such as the Aventus-Nomura joint venture. J.P. Morgan's selective aerospace and defense calls and a run of CEO successions suggest investors are rotating from richly valued AI and tech names toward earnings-backed value and leadership continuity.

Aventus Capital Inc.Fidelity National Financial, Inc.J.P. Morgan Chase Bank, N.A.Dominic Ng
crisis· mixed

AI-Chip Selloff Hits Semiconductors as Fundamentals Stay Strong

On Nov 5, 2026 the AI and data-center trade sold off hard. The PHLX Semiconductor Index had its worst session since March 2020, the S&P 500 had its worst day since the April 2025 tariff crash, and the Nasdaq entered correction. Nvidia leadership turmoil (reported CEO ouster plans and a spy scandal stalling export-curb tightening) and strategists downgrading US stocks and global tech to neutral added to the pressure. Company-level data stayed solid: Siltronic hit record 300mm shipments and narrowed 2026 guidance upward, and Lynx kept Micron and Sandisk at clear buy with 33% and 49% upside. Infineon's decision to stop disclosing backlog and a wave of consolidation (Winbond buying Infineon's NOR Flash and F-RAM business for USD 1.12B, Kalray/Bull) point to a cautious, restructuring phase. The Nov 6 and Nov 9 rebounds were only partial.

PHLX Semiconductor IndexNvidia spy scandalAI and data-center tradeBlue-Chip Stocks
Sinais que acompanhamos
  • Satellite-Terrestrial Network Integration Acceleration

    Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases

  • EPKINLY Regulatory-Clinical Success Cascade

    High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.

  • Smart Home AI Platform Convergence

    Samsung will likely announce a unified smart home AI platform or hub within 2-3 months that connects these disparate AI-enabled products

  • AI Integration Acceleration

    Sustained AI feature expansion across Samsung ecosystem in Q1-Q2 2026, with likely follow-up announcements for mobile devices and additional appliances

Hipóteses em estudo
  • NVIDIA GPU acceleration is becoming the dominant infrastructure for AI chip design and EDA workflows, creating a self-reinforcing ecosystem where AI chips are designed using AI-accelerated tools

    88% confidence · por testar
  • Data center infrastructure investments are shifting from traditional cloud providers to AI-specific facilities, with hyperscalers willing to commit $20B+ multi-year contracts for AI-optimized data center capacity, creating opportunities for specialized infrastructure developers

    88% confidence · por testar
  • LLM sycophancy is primarily caused by reinforcement learning from human feedback (RLHF) optimization for user approval rather than truthfulness, creating a systematic bias that degrades model reliability in extended conversations

    85% confidence · por testar
  • AI safety concerns are escalating as models gain access to classified and sensitive data, creating new security vulnerabilities and ethical challenges around training data governance

    85% confidence · por testar
  • Hyperscaler AI infrastructure investments exceeding $200B combined will drive semiconductor demand and AI chip production capacity expansion in 2026

    85% confidence · por testar
Sources we've traced
all →
Source document

Advanced Energy Reports Third Quarter 2026 Results

“Advanced Energy Reports Third Quarter 2026 Results Revenue was $696 million, up 50% year-over-year and above the high end of guidance Semiconductor and Data Center Computing revenue reached record levels, growing 64% and 49% year-over-year, respectively GAAP gross margin was 41.5%; non-GAAP gross margin was 42.1% GAAP…”

Source document

5 Worst Dow Stocks To Buy According to Analysts

“5 Worst Dow Stocks To Buy According to Analysts Yahoo Finance reported on November 5 that the Dow Jones Industrial Average tumbled 3.4%, or more than 1,800 points, while the S&P 500 fell 4.4% and the Nasdaq Composite sank 5.5% into correction territory…”

Source document

Oceaneering projects $390M–$440M EBITDA for 2026 as ADTech drives multiyear growth

“Oceaneering projects $390M–$440M EBITDA for 2026 as ADTech drives multiyear growth Earnings Call Insights: Oceaneering International, Inc…”

Source document

Corporate America’s big job cuts in 2026 - What do we know so far?

“Corporate America’s big job cuts in 2026 - What do we know so far? Corporate workers in America have faced the brunt of job cuts since the start of the year…”

Source document

Esperion Therapeutics and Corstasis Therapeutics Announce Esperion’s Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

“Esperion Therapeutics and Corstasis Therapeutics Announce Esperion’s Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray) – Enbumyst™ Is the First and Only FDA-Approved Nasal Spray Loop Diuretic for Edema Associated with Congestive Heart Failure, Expe…”

Source document

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

“Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress The combination of selinexor plus ruxolitinib met the first co-primary endpoint demonstrating a statistically significant improvement of spleen…”

Every fact is traceable to the document it came from: see how we source every claim.

Latest News

View All →
Mercados 24 horas e contratos de eventos: o que a eleição brasileira e os números da Robinhood revelam sobre a corrida contra os reguladores
Analysis

Mercados 24 horas e contratos de eventos: o que a eleição brasileira e os números da Robinhood revelam sobre a corrida contra os reguladores

Na eleição brasileira de 25 de outubro, os mercados de previsão apostaram na derrota errada, e as empresas correram para stablecoins. A Robinhood, com receita de contratos de eventos mais de seis vezes maior, mostra por que bolsas e reguladores dos EUA disputam as regras do mercado sempre ligado. Os números vêm de documentos da SEC.

ESMO 2026: a oncologia junta aprovações e dados, mas a Summit mostra o preço de chegar lá. Só a Summit gastou 1,08 mil milhões de dólares em 2025 sem vender nada
Analysis

ESMO 2026: a oncologia junta aprovações e dados, mas a Summit mostra o preço de chegar lá. Só a Summit gastou 1,08 mil milhões de dólares em 2025 sem vender nada

Em torno do congresso ESMO (Madrid, 23 a 27 de outubro) acumulam-se aprovações, dados de fase III e a promessa de IA na descoberta de fármacos. A Summit, que não tinha receita em 2023 e 2024, perdeu 1,08 mil milhões de dólares em 2025, segundo dados verificados em documentos da SEC. O dossiê não traz nada específico sobre Brasil ou Portugal.

Depois da eleição no Brasil, os mercados de previsão e as stablecoins deixam de ser teoria: a Robinhood já vê o negócio mudar de lugar
Analysis

Depois da eleição no Brasil, os mercados de previsão e as stablecoins deixam de ser teoria: a Robinhood já vê o negócio mudar de lugar

A corrida presidencial brasileira mostrou o que acontece quando mercados de previsão erram e quem precisa de proteção cambial corre para stablecoins. Os números da Robinhood, verificados em documentos da SEC, indicam para onde Wall Street está apostando. Também mostramos as divergências entre as fontes.

Mercados que não fecham, apostas em eventos e agentes de IA: o que a Robinhood mostra sobre o próximo ciclo das fintechs, e o que o segundo turno brasileiro revelou
Analysis

Mercados que não fecham, apostas em eventos e agentes de IA: o que a Robinhood mostra sobre o próximo ciclo das fintechs, e o que o segundo turno brasileiro revelou

O segundo turno brasileiro de 25 de outubro mostrou, em volumes reais, a procura por dólares digitais. Nos EUA, bolsas e reguladores preparam mercados quase 24 horas e contratos de eventos. Os números auditados da Robinhood indicam que a mudança já rende dinheiro. A avaliação da IA para cálculos financeiros é mais cautelosa.

Dow corta custos e a Union Pacific aposta na fusão: duas grandes industriais dos EUA tentam crescer sem esperar pela procura
Analysis

Dow corta custos e a Union Pacific aposta na fusão: duas grandes industriais dos EUA tentam crescer sem esperar pela procura

Nos resultados do 3.º trimestre de 2026, a Dow diz que o plano de custos está adiantado e que há cerca de 1,3 mil milhões de dólares de benefícios previstos para 2027. A Union Pacific regista resultados recordes e aposta numa fusão ferroviária. Os números vêm de filings da SEC e de transcrições, com as limitações indicadas.

Feito também para máquinas

Cada facto aqui é estruturado e rastreado à fonte, para que os sistemas de IA herdem a verdade de base, não afirmações reformuladas. Os mesmos factos que uma pessoa lê, um modelo pode consultar.

Obtenha via API →